Annual Congress Berlin 2008

---

---

High-risk patients for major lung cancer surgery

Symposium
Chairs: E. Quoix (Strasbourg, France), D. Subotic (Belgrade, Republic of Serbia)
Aims: At the end of the session, the expected benefit for the audience is as follows:
• To get insight into technological innovations that enable high-quality assessment of the overall perioperative risk (split lung function tests, effort studies, novelties related to the value of diffusion parameters).
• To become familiar with currently available perioperative monitoring and pain management.
• To find out how to balance the risks of multimodality treatment with the benefits of improved survival and quality of life. The risks of chemotherapy, radiotherapy and complications of surgery following neoadjuvant therapy will be particularly highlighted.
• To receive updated information about new possibilities and indications for mechanical ventilation for respiratory failure post-thoracotomy.

Preparation of high-risk patients for major lung cancer surgery C. Bolliger (Tygerberg, South Africa)
Multimodality lung cancer therapy – nonsurgical complications J. Vansteenkiste (Leuven, Belgium)
Mechanical ventilation for post-operative respiratory failure J. Masa (Caceres, Spain)